Venture Capital News: Breaking Venture Capital News, Comments and Articles. - Page: 4

04:40 EDT 23rd October 2014 | BioPortfolio

Venture Capital News - Page: 4RSS

Read the latest Venture Capital News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Venture Capital.

Search or Follow Our Venture Capital - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Venture Capital - Page: 4 News.

Showing "venture capital" News Articles 76 to 100 of 7,800+

Tuesday 21st October 2014

MetaStat Appoints Richard J. Berman and H. Philip Goodeve to Board of Directors

Decades of Experience Add Strength to Board MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company focused on understanding and treating systemic metastasis, appointed Richard J. Berman and H. Philip Goodeve to its Board of Directors, effective October 15. Mr. Berman and Mr. Goodeve replace Warren Lau and Dr. Patrick Mooney, both of whom have resi...

OrganiGram Announces Appointment of President

MONCTON, NEW BRUNSWICK -- (Marketwired) -- 10/21/14 -- OrganiGram Holdings Inc. (TSX VENTURE: OGI) (OTCQB: OGRMF) (the "Company") is pleased announce the appointment of Roger Rogers to the positio...

Ebola cases rise sharply in western Sierra Leone

After emerging months ago in eastern Sierra Leone, Ebola is now hitting the western edges of the country where the capital is located with dozens of people falling sick each day, the government said Tuesday. So many people are dying that removing bod...

Fidelity Biosciences and Atlas Venture Lead $12 Million Series A Funding to Launch Unum Therapeutics, a New Cellular Immunotherapy Company

- Unum has built a universal cellular immunotherapy platform based on proprietary antibody-coupled T-cell receptor (ACTR) technology Unum Therapeutics, a company developing cellular immunotherapy to treat cancer, announced today that it has raised $12 million in Series A fund

Aptose Biosciences Announces Approval For Listing On The Capital Market Shares To Begin Trading Under The Symbol APTO

SAN DIEGO and TORONTO, Oct. 21, 2014 /PRNewswire/ - Aptose Biosciences Inc. (Aptose) (TSX:APS), a clinical-stage company developing targeted agents and molecular diagnostics to treat the underlying mechanisms of cancer, announced today that its common shares...

ATI Announces Third Quarter 2014 Results

Third Quarter 2014 Results From Continuing Operations Sales were $1.07 billion Breakeven net income and EPS from continuing operations attributable to ATI Segment operating profit improved to $70.6 million, or 6.6% of sales $12.9 million of commissioning and qualification costs ...

UPDATE - ImmuPharma says institutional investor gets behind £3.4mln fundraiser

---ADDS SHARE PRICE & BROKER COMMENT--- ImmuPharma (LON:IMM) said it raised £3.4mln via a share placing at a premium to the market price to fund the ongoing development of its lead drug. The cash injection came principally from the group&rs...

Critical Outcome Technologies and MD Anderson Cancer Center to Evaluate COTI-2 in Treating Head and Neck Cancers / Initial results suggest that COTI-2 has potential for another unmet cancer need

LONDON, ONTARIO -- (Marketwired) -- 10/21/14 -- Critical Outcome Technologies Inc. ("COTI" or the "Company") (TSX VENTURE: COT) (OTCQB: COTQF), the bioinformatics and accelerated drug discovery co...

Olympus Selected as Innovation Partner and to Equip 35 ORs at Prestigious Karolinska University Hospital

Sweden’s “hospital of the future” chooses Olympus ENDOALPHA The Karolinska University Hospital in Stockholm has selected the Olympus ENDOALPHA control system for 35 operating rooms due to enter service when the hospital opens in 2016. ENDOALPHA is an integrated platform for controlling every medical device in OR and simplifying communication pro...

Viamet Announces $60 Million Series D Financing

Viamet Pharmaceuticals Holdings, LLC (Viamet) today announced the closing of a $60 million Series D financing provided by Brandon Point Industries Limited (Brandon Point) working with Woodford Investment Management. In making this commitment, Brandon Point and Woodford Investment Management join Viamet’s current investor syndicate, which includes Novarti...

Aurora Spine Corporation : AURORA SPINE ANNOUNCES GLOBAL DISTRIBUTION AGREEMENT FOR SENTIOMMG® NERVE MAPPING SYSTEM

Carlsbad, California, October 21, 2014 /Marketwired/ - Aurora Spine Corporation (TSX VENTURE:ASG) announced today that it has entered into a worldwide distribution and co-marketing agreement with Sentio, LLC to distribute the SentioMMG® nerve mapping system.    Sentio has pioneered a game changing method for mapping nerve location, resulting in improved technology for surgeons to use as c...

ISOThrive Raises $1.4 Million to Accelerate Market Entry

Food Products Targeted at Improving Microbiome Health ISOThrive LLC, a new food and dietary supplement company and a leader in the effort to improve the health of the microbiome, recently completed a $1.4 million round of private investment. The funding, provided by leaders in innovative food products, dietary supplements, marketing and financial servi...

Capital Senior Living Corporation Announces Release Date for Third Quarter 2014 Financial Results

Capital Senior Living Corporation (NYSE:CSU) will host a conference call with senior management to discuss the Company’s third quarter 2014 financial results. The call will be held on Tuesday, November 4, 2014 at 5:00 p.m. Eastern Time. The Company’s earnings announcement is scheduled to be released to news services after the market closes on Tuesday, ...

Consort Medical to Acquire Aesica Pharmaceuticals for £230 Million

Consort Medical announced that it has agreed terms to acquire the entire issued and to be issued share capital of Aesica Pharmaceuticals for £230 million.

NTRR Sees Big Money Ballot Initiatives as Major Tipping Point for Cannabis Market in November

The push to expand the market for legal cannabis in the U.S. is attracting big money for ballot measures set to go before voters in Florida, Oregon and Alaska in November’s mid-term elections, which means good news for Neutra Corp. (OTCBB:NTRR) and other ancillary businesses who potentially stand to profit immensely as the demand for cannabis continues t...

Pan's Ink and Michigan Hemp Co Team Up to Deliver Terpene-Infused Hemp CBD Products

LOS ANGELES, Oct. 21, 2014 /PRNewswire/ -- Pan's Ink and Michigan Hemp Company announce today that they have entered into a strategic supply agreement whereby Pan's Ink will provide tailored, natural terpene mixtures in bulk to Michigan Hemp Company (MHC) for use in MHC's Hemp CBD products. Pan's Ink will distribute its terpene mixtures to Michigan Hemp Co under the Pan's Ink brand, TerpAid&#...

OneBeacon Professional Insurance's Holmes To Chair Advisen Cyber Risk Insights Conference

MINNETONKA, Minn., Oct. 21, 2014 /PRNewswire/ -- OneBeacon Professional Insurance (OBPI), a member of OneBeacon Insurance Group, Ltd. (NYSE:OB), today announced that Kim Holmes, Vice President of Product Development, will be a Chairperson at the upcoming Advisen 2014 Cyber Risk Insights Conference in New York City on October 28. Holmes will chair the Health Care Cyber Liability track, includ...

China Materialia Leads $5.7 Million Investment in ZipLine Medical

China Materialia LLC, a Shanghai-based venture capital company, led a $5.7 million extension to a Series C financing for ZipLine Medical of California. ZipLine makes novel noninvasive surgical skin closure products. China Materialia's Fund I has $26 ...

Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO

SAN DIEGO and TORONTO, Oct. 21, 2014 /PRNewswire/ - Aptose Biosciences Inc. (Aptose) (TSX:APS), a clinical-stage company developing targeted agents and molecular diagnostics to treat the underlying mechanisms of cancer, announced today that its common shares have been approved for listing on the NASDAQ Capital Market under the symbol "APTO". Aptose will begin trading on NASDAQ on or around ...

JZ Capital Partners To Sell Stake In Milestone Aviation To GE Capital Aviation

FAIRFIELD (dpa-AFX) - JZ Capital Partners Limited (JZCP.L), the London and Channel Islands listed private equity fund which invests in high quality US and European micro-cap companies, said that i...

ISTO Technologies to Present at 12th Annual 2014 Musculoskeletal New Ventures Conference

ST. LOUIS, Oct. 21, 2014 /PRNewswire/ -- ISTO Technologies, Inc., a privately-held regenerative medicine company, announced today announced that Scott Gill, the Company's Chief Financial Officer, will present at the 12th Annual 2014 Musculoskeletal New Ventures Conference as follows:  Event:   12th Annual 2014 Musculoskeletal New Ventures Conference Date: October 2...

Liftstream report finds ten men for every woman present in biotech boardrooms

Unstructured hiring practices and over-reliance on personal networks is limiting opportunities for women in biotech Germany and The Netherlands have the lowest proportion of women in the boardroom (4.1%), compared to Scandinavia (15.5%) and France (17.4%) But there are twice as many women in corporate VC compared to ...

ImmuPharma says institutional investor gets behind £3.4mln fundraiser

ImmuPharma (LON:IMM) said it raised £3.4mln via a share placing at a premium to the market price to fund the ongoing development of its lead drug. The cash injection came principally from the group’s long-standing institutional backer, Av...

First Patient Successfully Implanted in Safety/Efficacy Study of Beta-O2's ßAir Bio-Artificial Pancreas for Type 1 Diabetes

ROSH HAAYIN, Israel, October 21, 2014 /PRNewswire/ -- Beta-O2 announced today that the first patient participating in the company's first broad study of the ßAir Bio-Artificial Pancreas has been successfully implanted.   ßAir is in development as a treatment and a potential cure for type 1 diabetes (T1D). Approximately 3 million people have T1D in the U.S.     ...

Inovio Pharmaceuticals, MedImmune and the University of Pennsylvania Partner to Combat Influenza and Antibiotic Resistant Bacteria

PLYMOUTH MEETING, Pa., Oct. 21, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the University of Pennsylvania; Inovio Pharmaceuticals; and MedImmune, the global biologics research...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks